Informed Consent
Item
must understand and voluntarily sign an informed consent form.
boolean
C0021430 (UMLS CUI [1])
Age
Item
must be ≥ 18 years of age at the time of signing the informed consent form.
boolean
C0001779 (UMLS CUI [1])
Protocol Compliance
Item
must be able to adhere to the study visit schedule and other protocol requirements.
boolean
C0525058 (UMLS CUI [1])
T-Cell Lymphoma
Item
biopsy-proven t-cell non-hodgkin's lymphoma, either:
boolean
C0079772 (UMLS CUI [1])
Peripheral T-Cell Lymphoma Subtype Any
Item
peripheral t-cell lymphoma (ptcl) whatever the subtype, or
boolean
C0079774 (UMLS CUI [1,1])
C0449560 (UMLS CUI [1,2])
C1552551 (UMLS CUI [1,3])
Cutaneous t-cell lymphoma/Mycosis fungoides
Item
cutaneous t-cell lymphoma (ctcl), but only the subtype mycosis fungoides.
boolean
C0026948 (UMLS CUI [1])
Prior Therapy | T-cell lymphoma recurrent | T-cell lymphoma refractory
Item
relapsed or refractory to previous therapy for t-cell non-hodgkin's lymphoma.
boolean
C1514463 (UMLS CUI [1])
C0854826 (UMLS CUI [2])
C0854827 (UMLS CUI [3])
Combination Chemotherapy Quantity
Item
must have received at least one prior combination chemotherapy regimen. there is no limit on the number of prior therapies.
boolean
C1521750 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Cutaneous T-cell lymphoma/Sezary Syndrome
Item
cutaneous t-cell lymphoma of subtype sézary syndrome.
boolean
C0036920 (UMLS CUI [1])